SUMMARY
Cardiac myocytes from the mdx mouse, the mouse model of Duchenne muscular dystrophy, exhibit t-tubule disarray and increased calcium sparks, but a unifying molecular mechanism has not been elucidated. Recently, improper trafficking of junctophilin (JPH)-2 on an altered microtubule network caused t-tubule derangements and calcium mishandling in a pressure-overload heart failure model. Mdx cardiac myocytes have microtubule abnormalities, but how this may affect JPH-2, t-tubules, and calcium handling has not been established. Here, we investigated the hypothesis that an inverse relationship between microtubules and JPH-2 underlies t-tubule disruptions and calcium mishandling in mdx cardiac myocytes. Confocal microscopy revealed t-tubule disorganization in mdx cardiac myocytes. Quantitative Western blot analysis demonstrated JPH-2 was decreased by 75% and showed an inverse hyperbolic relationship with aand b-tubulin, the individual components of microtubules, in mdx hearts. Colchicine-induced microtubule depolymerization normalized JPH-2 protein levels and localization, corrected t-tubule architecture, and reduced calcium sparks. In summary, these results suggest microtubule- (1) . Heart failure is the cause of death for 20% to 25% of DMD patients (2) ; therefore research aimed at understanding the molecular and cellular phenotypes underlying the cardiomyopathy of DMD has been conducted. Altered calcium homeostasis marked by increased calcium sparks (3) (4) (5) and t-tubule disarray were documented in cardiac myocytes from the dystrophin-deficient mdx mouse (6, 7) , but a unifying molecular mechanism has not been identified.
Junctophilin (JPH)-2, the protein that links the plasma membrane of t-tubules to the ryanodine receptor, is essential for proper t-tubule structure and function (8) . Recently, it was reported that JPH-2 mislocalization due to abnormalities in microtubule cytoskeleton caused pathological t-tubule remodeling and abnormal calcium handling in the pressure overload-induced heart failure model (9) . However, the relationship between microtubules and JPH-2 in other models of heart failure or cardiomyopathy has not been analyzed. Because previous studies documented microtubule derangements in mdx cardiac myocytes (5, 10) , we tested the hypothesis that microtubule alterations cause JPH-2 misregulation and result in t-tubule disruptions and calcium mishandling in mdx mice.
Finally, to investigate the translational aspects of our hypothesis, we examined the cardiomyopathy of mdx mice via echocardiography and isoproterenol stress tests as previous studies showed mildly reduced systolic function (11) (12) (13) (14) and excessive mortality with isoproterenol administration (10, 15, 16) in mdx mice. 
METHODS

MICE.
Control C57BL/10 and mdx mice were purchased from Jackson Laboratories. All animals were housed and treated following the guidelines set forth by the University of Minnesota Institutional Animal Care and Use Committee.
ANTIBODIES. Polyclonal antibodies for voltage-gated calcium channel (VGCC) (Sigma, Waltham, Massachusetts) and JPH-2 (ThermoScientific) and monoclonal antibodies for a-tubulin (Sigma), b-tubulin (Sigma), and dystrophin (Leica, Buffalo Grove, Illinois) were purchased from the identified vendors.
Alexa-Fluor-488
or Alexa-Fluor-568Àconjugated
anti-rabbit antibodies were purchased from Molecular Probes (Eugene, Oregon). Infrared dye-conjugated anti-mouse and anti-rabbit antibodies were purchased from LICOR Biosciences (Lincoln, Nebraska).
ISOLATION OF CARDIAC MYOCYTES. Isolation of ventricular cardiac myocytes was performed as described previously (18) .
T-TUBULE ASSESSMENT. Freshly isolated cardiac myocytes were fixed in 4% paraformaldehyde for 10 min at 37 C, washed with phosphate-buffered saline (PBS) 2 times for 5 min, incubated with AlexaFluor 488 . T-tubule quantification was performed using the TT Power plugin on ImageJ as described (7) . Whole protein extracts from isolated ventricles from mice were performed as described (19 We first analyzed the t-tubule network in isolated cardiac myocytes from young (2-to 3-months old) and older (8-to 10-months old) WT and mdx mice. The 8-to 10-month time was used because that is the age when mdx mice begin to show signs of cardiomyopathy (12, 14) . When compared to 8-month to 10-months of age, WT and young mdx cardiac myocytes had no discernable difference in t-tubule architecture, but older mdx cardiac myocytes showed disrupted t-tubules ( Figure 1A) . When quantified using TT Power analysis, older mdx t-tubule structural integrity (39.2 AE 2.2 AU) was significantly different than WT (57.3 AE 1.3 AU) and young mdx mice (56.8 AE 2.3 AU) ( Figure 1B) .
To provide insight into the mechanism of t-tubule disruptions in older mdx mice, we investigated 2 key t-tubule proteins: the VGCC and JPH-2. Protein levels of VGCC were not altered in either young or older mdx heart extracts ( Figures 1C to 1F) . However, JPH-2 protein levels were markedly reduced by 75% in older mdx hearts (WT: 1 AE 0.9 AU and mdx: 0.024 AE 0.4 AU)
but not significantly altered in young mice (WT: 1.0 AE Figures 2C and 2D) .
When the relationships between aand b-tubulin and JPH-2 in older mice was analyzed, we observed a significant inverse hyperbolic relationships (r 2 ¼ 0.95 Abbreviations as in Figure 1 .
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for both curve fitting models) (Figures 2E and 2F ).
These data suggested increased microtubule content was associated with reduced JPH-2 protein levels. 2 AU) ( Figures 3F and 3G) . To further investigate ryanodine receptor activity, we measured calcium spark frequency and found acute colchicine treatment reduced calcium sparks by more than 50% (mdx: 0.84 AE 0.2 sparks/s/100 mm and mdx-colchicine: 0.31 AE 0.08 sparks/s/100 mm) ( Figures 4G and 4H) . Acute colchicine treatment caused a nonsignificant alteration in sarcoplasmic reticulum calcium load (Supplemental Figure 1) , which would not explain the reduction in calcium sparks. All together, these data suggest that acute colchicine treatment improved ryanodine receptor gating in mdx cardiac myocytes.
groups showed signs of mild cardiomyopathy when compared to age-matched WT mice. Finally, colchicine treatment did not confer a significant survival benefit when older mdx mice were subjected to isoproterenol stress test (WT survival: 75%, mdx-colchicine survival:
40%, mdx-PBS survival: 10%) (Supplemental Figure 3) . showed normalization of calcium transients in cells cultured for >48 h. Nonetheless, our results support a crucial role for JPH-2 in regulating ryanodine receptor activity.
Although we were able to document restoration of t-tubule organization with colchicine treatment, we did not observe organ-level cardiac improvements in mdx mice. One explanation is that t-tubule corrections do not always lead to improved whole organ function; a finding that was documented in previous publications. Firstly, t-tubule derangements precede left ventricular dysfunction in the thoracic aortic banded rat model (26) . Moreover, while transgenic overexpression of JPH-2 could prevent pathological t-tubule remodeling and blunted the effects of aortic banding; it did not completely prevent the onset of heart failure (17) . Another reason for the lack of improvement of cardiomyopathy in mdx mice treated with colchicine could be the relatively mild cardiomyopathy of mdx mice. Whereas Guo et al. (17) showed improvements in ejection fraction with JPH-2 overexpression, there was not a complete normalization of ejection fraction, which could explain why echocardiography did not reveal improvements in mdx mice treated with colchicine as the mdx mice had only mild reduced fractional shortening (Supplemental Figure 2) . Finally, the lack of a significant improvement in isoproterenol stress test may be explained by the underlying pathophysiology that was corrected with colchicine treatment. Previously, membrane permeability was associated with increased death in mdx mice when treated with isoproterenol (10, 15, 16) , and thus the nonsignificant improvement in survival with colchicine may have resulted from an inability to correct cardiac myocytes permeability in mdx hearts. In summary, there may be several reasons why colchicine treatment did not improve mdx cardiomyopathy.
Finally, our results add to several other publications that document a crucial role for JPH-2 in t-tubule integrity. The first link between JPH-2 and t-tubules was shown when knockout of JPH-2 resulted in embryonic lethality due to lack and cardiac contractility and improper t-tubule formation (27) . Several other studies document that alterations of JPH-2 via miR-24 (28, 29) , RNA interference (21, 22, 30) , or calpain-mediated protein cleavage ( 
